Taipei Medical University

Meet Joey Rabbit, the New AI-Powered 3D Virtual Mental Health Butler from Bamboo Technology

Retrieved on: 
Monday, November 6, 2023

TAIPEI, Nov. 6, 2023 /PRNewswire/ -- Bamboo Technology, a mental health technology innovation company, is thrilled to unveil Joey Rabbit, a state-of-the-art 3D virtual mental health butler that is the new face of its digital mental health app Here Hear. Developed in collaboration with Taipei Medical University and Nenghuo Animation, Joey Rabbit is poised to revolutionize the field of AI-powered virtual mental health support.

Key Points: 
  • Debuts at 4th anniversary celebration of company's mental health app Here Hear, organized around World Mental Health Day 2023
    TAIPEI, Nov. 6, 2023 /PRNewswire/ -- Bamboo Technology, a mental health technology innovation company, is thrilled to unveil Joey Rabbit, a state-of-the-art 3D virtual mental health butler that is the new face of its digital mental health app Here Hear.
  • Developed in collaboration with Taipei Medical University and Nenghuo Animation, Joey Rabbit is poised to revolutionize the field of AI-powered virtual mental health support.
  • For healthcare providers, military personnel, social workers, educators, and other frontline workers, Bamboo is offering 1 month of Here Hear for free.
  • This year's celebration embraced the theme "Mental Health is a Universal Human Right," which resonates deeply with Bamboo Technology's mission, emphasizing the importance of equal access to mental healthcare for all.

AiViva Biopharma Appoints Jung-Chin (Rongjin) Lin, to the Board of Directors

Retrieved on: 
Wednesday, August 30, 2023

He is Honorary President of Center Laboratories, Inc. and Chairman of the Board of Lumosa Therapeutics Co., Ltd. and Glac Biotech Co., Ltd.

Key Points: 
  • He is Honorary President of Center Laboratories, Inc. and Chairman of the Board of Lumosa Therapeutics Co., Ltd. and Glac Biotech Co., Ltd.
  • “It is a great honor and pleasure to be introduced to and join the board of AiViva Holding Limited and AiViva BioPharma.
  • “I am honored to welcome Mr. Lin to the board of directors.
  • “AiViva is positioned for success internationally and Mr. Lin will be a key member of our Board of Directors, guiding AiViva to the next phase of growth.”

DSFederal and Taipei Medical University Forge Partnership to Promote Innovation in Data Science Technologies

Retrieved on: 
Tuesday, August 22, 2023

ROCKVILLE, Md., Aug. 22, 2023 /PRNewswire/ -- DSFederal, Inc. , a government-focused leader in data science and digital solutions, and Taipei Medical University (TMU), a top-ranked biomedical higher education institution, announced the establishment of a Biomedical Informatics Partnership Program (BIPP) to promote innovation, global relationships, and international collaboration.

Key Points: 
  • ROCKVILLE, Md., Aug. 22, 2023 /PRNewswire/ -- DSFederal, Inc. , a government-focused leader in data science and digital solutions, and Taipei Medical University (TMU), a top-ranked biomedical higher education institution, announced the establishment of a Biomedical Informatics Partnership Program (BIPP) to promote innovation, global relationships, and international collaboration.
  • TMU is home to eleven medical colleges that span from medicine and public health to medical science and technology and biomedical engineering.
  • It is also affiliated with six hospitals in Taiwan including the Taipei Cancer Center and the Taipei Neuroscience Institute.
  • "Leveraging the thinking and insights of the brightest minds, wherever they may happen to reside, is key in driving the practical value of data science and services," said Clement Chen, CEO of DSFederal.

Alliance Memory Further Bolsters Presence in Asia With Appointment of Kelly Chien as Country Manager for Taiwan

Retrieved on: 
Monday, June 26, 2023

KIRKLAND, Wash., June 26, 2023 (GLOBE NEWSWIRE) -- Alliance Memory today announced that it has further strengthened its market presence in Asia with the appointment of Kelly Chien as the company’s country manager for Taiwan.

Key Points: 
  • KIRKLAND, Wash., June 26, 2023 (GLOBE NEWSWIRE) -- Alliance Memory today announced that it has further strengthened its market presence in Asia with the appointment of Kelly Chien as the company’s country manager for Taiwan.
  • In her new role, she will work closely with Alliance Memory’s distribution partners to expand the company’s sales coverage in the country.
  • Ms. Chien brings 17 years of experience in the semiconductor industry to Alliance Memory.
  • "Recently, we’ve doubled-down on our efforts to expand our market presence in Asia, first in Korea, and now in Taiwan with Kelly at the helm,” said David Bagby, president and CEO of Alliance Memory.

AI Startup AESOP Raises $3M to Tackle Medical and Billing Errors

Retrieved on: 
Wednesday, August 31, 2022

SAN FRANCISCO, Aug. 31, 2022 /PRNewswire/ -- Digital health startup AESOP Technology has raised a $2.95 million series pre-A round to address the growing medical and billing errors problem.

Key Points: 
  • SAN FRANCISCO, Aug. 31, 2022 /PRNewswire/ -- Digital health startup AESOP Technology has raised a $2.95 million series pre-A round to address the growing medical and billing errors problem.
  • Originally from Taiwan, AESOP started as a universityspin-off from Taipei Medical University (TMU).Professor Yu Chuan (Jack)Li, the founder and current president of the International Medical Informatics Association,spent tenyears before AESOP working on big data approaches to reduce medication errors.
  • He initially applied the model to launch a product, RxPrime (previously known asMedGuard), that identifies wrong-drug errors.
  • They worked together to broaden the types of errors the AI could identify and on products they could use to improve the US healthcare system.

Taiwan's CancerFree Biotech Ltd Develops World's First Commercial Personalized Cancer Cell Profile

Retrieved on: 
Friday, July 29, 2022

Stage 2 patients or above shortens the drug therapy selection process through a personalized cancer profile, the innovative technology will be showcasing at US Bio 2022.

Key Points: 
  • Stage 2 patients or above shortens the drug therapy selection process through a personalized cancer profile, the innovative technology will be showcasing at US Bio 2022.
  • CancerFree Biotech's CDO system develops a personalized patient cancer profile (called an 'avatar') by culturing their cancer cells in a lab to simulate the body's response to a drug.
  • This increases the number of cancer cells we can work with to build a tumor avatar (tumor profile) of the patient.
  • This is why CancerFree Biotech's innovative CDO system boasts high efficacy, successfully proliferating cancer cells ex vivo in approximately 90% more than 100 cancer types.

Preclinical Immunotherapy Research Featured in Poster Presentation at AACR 2022 Annual Meeting Highlights YIV-906’s Immunomodulatory Mechanisms in Combination with Immune Checkpoint or CAR T Therapy

Retrieved on: 
Friday, April 8, 2022

NEW HAVEN, Conn and NEW YORK and SHANGHAI, April 08, 2022 (GLOBE NEWSWIRE) -- Yiviva and Yale scientists will present new data from Yiviva’s oncology portfolio at the 2022 American Association for Cancer Research (AACR) Annual Meeting in New Orleans on April 8-13, 2022.

Key Points: 
  • YIV-906 has the potential to be developed as a platform oncology therapeutic when administered in combination with chemotherapy, immunotherapy and radiation therapies, in multiple cancer indications.
  • YIV-906 has shown promise in preliminary clinical studies in liver, pancreatic, colorectal and rectal cancers.
  • Yiviva is a clinical stage, platform biotechnology company developing multi-targeted, systems biology therapeutics, focused on cancer and inflammatory diseases.
  • The company was launched with Yale University as a co-founder and co-founders include Yung Chi Cheng, Ph.D. For further information, please visit https://yiviva.com .

Tang Prize Laureates Reflect on the Breakthroughs Made Possible by Cytokine Research

Retrieved on: 
Saturday, November 27, 2021

Charles Dinarello, Marc Feldmann, and Tadamitsu Kishimoto, providing valuable informaiton on the role cytokines play in inflammation and the COVID-19 disease as well as possible treatments.

Key Points: 
  • Charles Dinarello, Marc Feldmann, and Tadamitsu Kishimoto, providing valuable informaiton on the role cytokines play in inflammation and the COVID-19 disease as well as possible treatments.
  • It was a journey that took them from basic research to drug development and clinical application.
  • These three lectures by the 2020 Tang Prize laureates in Biopharmaceutical Science will be premiered on the Tang Prize YouTube channel from 4 p.m. to 7 p.m. (GMT+8) on November 27.
  • To watch the complete version of the "2020 Tang Prize Laureate's Lectures for Biopharmaceutical Science," please consult the schedule below.

Tang Prize Laureates Reflect on the Breakthroughs Made Possible by Cytokine Research

Retrieved on: 
Saturday, November 27, 2021

Charles Dinarello, Marc Feldmann, and Tadamitsu Kishimoto, providing valuable informaiton on the role cytokines play in inflammation and the COVID-19 disease as well as possible treatments.

Key Points: 
  • Charles Dinarello, Marc Feldmann, and Tadamitsu Kishimoto, providing valuable informaiton on the role cytokines play in inflammation and the COVID-19 disease as well as possible treatments.
  • In 1977, the research outcomes were published in the Proceedings of the National Academy of Sciences.
  • He also shed light on IL-6's effects on autoimmune diseases and how IL-6 can trigger cytokine storms.
  • To help the public gain a better understanding of the latest progress made in biomedical sciences, the Tang Prize Foundation will make these three lectures available on its official website ( https://www.tang-prize.org ) afterwards.

FUTEX displays 70 innovative projects in first ever cross-domain exhibition zone

Retrieved on: 
Tuesday, October 19, 2021

The Future Tech Theme Pavilion (FUTEX) at 2021 Taiwan Innotech Expo (TIE), set up by the Ministry of Science and Technology (MOST), with the backing of Academia Sinica, the Ministry of Education and the Ministry of Health and Welfare, featured for the first time a special cross-domain integration zone, with 70 innovative cross-domain projects taking stage at the exhibition.

Key Points: 
  • The Future Tech Theme Pavilion (FUTEX) at 2021 Taiwan Innotech Expo (TIE), set up by the Ministry of Science and Technology (MOST), with the backing of Academia Sinica, the Ministry of Education and the Ministry of Health and Welfare, featured for the first time a special cross-domain integration zone, with 70 innovative cross-domain projects taking stage at the exhibition.
  • Fusion Medium served as the media partner of the event.
  • With the rapid growth of digital technology, the healthcare and technology sectors, which were in the past sharply divided from each other, have gradually become connected.
  • The COIVD-19 outbreak has created an urgent need for drug development to treat the symptoms of the virus.